NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹82 Cr | ₹90 Cr | ₹66 Cr | ₹64 Cr | ₹38 Cr |
What is the latest Sundry Debtors ratio of NGL FINECHEM ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹82 Cr |
| Mar2024 | ₹90 Cr |
| Mar2023 | ₹66 Cr |
| Mar2022 | ₹64 Cr |
| Mar2021 | ₹38 Cr |
How is Sundry Debtors of NGL FINECHEM Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹82 Cr | -9.00 | |
| Mar2024 | ₹90 Cr | 36.05 | |
| Mar2023 | ₹66 Cr | 2.96 | |
| Mar2022 | ₹64 Cr | 70.35 | |
| Mar2021 | ₹38 Cr | - | |
Compare Sundry Debtors of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹2,004.0 Cr | 4.3% | 25% | 208.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 4.3% |
25% |
208.7% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses